Researcher
Felix Mottaghy
- Disciplines:Medical imaging and therapy, Medicinal products
Affiliations
- Nuclear Medicine & Molecular Imaging (Division)
Member
From26 Feb 2007 → 30 Sep 2009
Projects
1 - 2 of 2
- Implementation of functional imaging and molecular diagnostics for patient-tailored treatment of prostate cancer.From1 Jan 2009 → 30 Sep 2015Funding: Ministery of Social Affairs, Public Health and Environment
- A phase I dose-escalation study to determine the maximum tolerated dose of radiotherapy, in combination with concomitant 5-FU chemptherapy, in patients with locally advanced rectal cancer with a positive circumferential resection margin (cCRM).From1 Jan 2009 → 31 Dec 2010Funding: Private funding of national origin - undefined
Publications
1 - 10 of 286
- The battle on time, money and precision: Da[18F] id vs. [68Ga]liath(2020)
Authors: Felix Mottaghy
Pages: 2944 - 2946 - HER2-directed antibodies, affibodies and nanobodies as drug-delivery vehicles in breast cancer with a specific focus on radioimmunotherapy and radioimmunoimaging(2020)
Authors: Betuel Altunay, Agnieszka Morgenroth, Mohsen Beheshti, Andreas Vogg, Nicholas CL Wong, Hong Hoi Ting, Hans-Juergen Biersack, Elmar Stickeler, Felix Mottaghy
Pages: 1371 - 1389 - Is 68Ga-DOTA-FAPI a new arrow in the quiver of dose painting in radiation dose planning in head and neck cancers?(2020)
Authors: Felix Mottaghy
Pages: 2718 - 2720 - Brown adipose tissue uptake of triglyceride-rich lipoprotein-derived fatty acids in diabetic or obese mice under different temperature conditions(2020)
Authors: Andreas Paulus, Natascha Drude, Wouter van Marken Lichtenbelt, Felix Mottaghy, Matthias Bauwens
- Magnetic resonance imaging of carotid plaques: current status and clinical perspectives(2020)
Authors: Mohamed Kassem, Alexandru Florea, Felix Mottaghy, Robert van Oostenbrugge, M Eline Kooi
- Multiphasic Ga-68-PSMA PET/CT in the Detection of Early Recurrence in Prostate Cancer Patients with a PSA Level of Less Than 1 ng/mL: A Prospective Study of 135 Patients(2020)
Authors: Mohsen Beheshti, Reyhaneh Manafi-Farid, Hans Geinitz, Reza Vali, Wolfgang Loidl, Felix Mottaghy, Werner Langsteger
Pages: 1484 - 1490 - Development of Radiotracers for Breast Cancer-The Tumor Microenvironment as an Emerging Target(2020)
Authors: Amelie Heesch, Jochen Maurer, Elmar Stickeler, Mohsen Beheshti, Felix Mottaghy, Agnieszka Morgenroth
- An International Multi-Center Investigation on the Accuracy of Radionuclide Calibrators for Theranostics in Nuclear Medicine(2020)
Authors: C Saldarriaga Vargas, M Bauwens, INA Pooters, S Pomme, SMB Peters, M Segbers, W Jentzen, A Vogg, FHP van Velden, SL Meyer Viol, et al.
Pages: S315 - S315 - Inflammation-Based Index and 68Ga-DOTATOC PET-Derived Uptake and Volumetric Parameters Predict Outcome in Neuroendocrine Tumor Patients Treated with 90Y-DOTATOC(2020)
Authors: Elin Pauwels, Vincent Vandecaveye, Kristof Baete, Michel Koole, Felix Mottaghy, Karin Haustermans, Paul Clement, Kristiaan Nackaerts, Chris Verslype, Christophe Deroose
Pages: 1014 - 1020 - Advancements in PARP1 Targeted Nuclear Imaging and Theranostic Probes(2020)
Authors: Ramya Ambur Sankaranarayanan, Susanne Kossatz, Wolfgang Weber, Mohsen Beheshti, Agnieszka Morgenroth, Felix Mottaghy